| Type | MGI:General | Description | AOM/DSS-treated mice show a skewed Th1-Th2 cytokine balance, showing elevated Th2-type cytokines (IL-13, IL-4, IL-5) and IL-17 colonic expression and increased levels of the Th2 differentiation marker GATA3, indicating a dominant type 2 immune response AOM only treated mice also show higher colonic expression of IL-13, IL-5, IL-10, and IL-17 than in controls |
